Mecoverge-NT 37.5 Tablet
Marketer
Mediverge Healthcare Pvt Ltd
Salt Composition
Pregabalin (37.5mg) + Nortriptyline (10mg)
Overview Mecoverge-NT 37.5 Tablet
Neuropathic pain relief is provided by the combined medication, NerveCalm 37.5mg tablets. This formulation interrupts pain signal transmission to the brain, thereby reducing pain perception. NerveCalm 37.5mg tablets are administered orally, with or without food, ideally before sleep. Consistent daily dosing, at the same time, ensures stable blood levels. Adhere strictly to your physician's prescribed dosage and duration, as this medication can be habit-forming. Missed doses should be taken immediately upon recollection. Complete the entire course of treatment, even if symptoms improve. Ceasing this medication abruptly is strongly discouraged without prior consultation with your doctor. Common adverse effects may include constipation, urinary difficulties, weight increase, fatigue, and dry mouth. Dizziness and drowsiness are also possible; avoid driving or tasks demanding concentration until the medication's effects are understood. Weight gain can occur; regular exercise and a balanced diet are recommended to mitigate this. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your physician immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a comprehensive list of all other medications currently being taken, as interactions may affect efficacy or function. Pregnancy, pregnancy planning, or breastfeeding should also be reported to your doctor.
Uses of Mecoverge-NT 37.5 Tablet
Managing neuropathic pain
Major Benefits of Mecoverge-NT 37.5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mecoverge-NT 37.5 Tablet whole; avoid crushing, chewing, or breaking it. Consumption with or without food is acceptable, however, consistent timing is recommended.
Common Side effects of Mecoverge-NT 37.5 Tablet:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Mecoverge-NT 37.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Mecoverge-NT 37.5 Tablets can be ingested with or without food, although consistent timing is recommended.
How Mecoverge-NT 37.5 Tablet works:
Mecoverge-NT 37.5 Tablets combine pregabalin and nortriptyline to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain by regulating calcium channel function in nerve cells. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline, neurotransmitters that inhibit pain signal transmission within the brain. This dual action provides effective relief from nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecoverge-NT 37.5 Tablet and alcohol may result in significantly increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Mecoverge-NT 37.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Mecoverge-NT 37.5 Tablet while breastfeeding is likely unsafe. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Mecoverge-NT 37.5 Tablet side effects, due to potential drowsiness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Mecoverge-NT 37.5 Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mecoverge-NT 37.5 Tablet in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Mecoverge-NT 37.5 Tablet :
Should you forget a Mecoverge-NT 37.5 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecoverge-NT 37.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |



